MONROVIA, Calif., June 1, 2005 /PRNewswire-FirstCall via COMTEX/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it has been invited to present at the Pacific Growth Equities 2005 Life Sciences Growth Conference at the InterContinental Mark Hopkins Hotel in San Francisco on Monday, June 6, 2005. The Company is scheduled to discuss its business strategy and historical financial performance at 2:00 p.m. Pacific Time.

Attendance at the conference is by invitation only. STAAR Surgical will offer a live audio-only webcast of its presentation which may be accessed at STAAR's website at www.staar.com. An archived replay of the presentation will also be available immediately following on STAAR's website.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the revolutionary VISIAN ICL(TM) as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. STAAR's ICL has received CE Marking, is approved for sale in approximately 40 countries and has been implanted in more than 40,000 eyes worldwide. It is currently under review by the FDA, but not yet approved, for use in the United States.

CONTACT:   Investors
                EVC Group
                Douglas Sherk, 415-896-6820
                Jennifer Beugelmans, 415-896-6820

                Media
                EVC Group
                Steve DiMattia, 917-620-0590

SOURCE STAAR Surgical

Investors, Jennifer Beugelmans, +1-415-896-6820, or Douglas Sherk, +1-415-896-6820,
or Media, Steve DiMattia, +1-917-620-0590, all of EVC Group

http://www.prnewswire.com